US Representative

Dan Crenshaw 2023-2024 Regular Session - Authored & Sponsored Legislation (Page 10)

Legislative Session

Co-Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4136

Introduced
6/14/23  
Refer
6/14/23  
Refer
7/25/23  
U.S. Congressman Sam Johnson Memorial VA Clinic Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4167

Introduced
6/15/23  
Refer
6/15/23  
Refer
6/16/23  
Protecting America’s Distribution Transformer Supply Chain Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4175

Introduced
6/15/23  
Refer
6/15/23  
REPO for Ukrainians Act Rebuilding Economic Prosperity and Opportunity for Ukrainians Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4238

Introduced
6/21/23  
Kate's Law Stop Illegal Reentry Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB427

Introduced
1/20/23  
Refer
1/20/23  
Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4316

Introduced
6/23/23  
Refer
6/23/23  
Citizen Ballot Protection Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB435

Introduced
1/20/23  
Protecting Life on College Campus Act of 2023 This bill prohibits the award of federal funds to an institution of higher education (IHE) that hosts or is affiliated with a school-based service site that provides abortion drugs or abortions to its students or to employees of the IHE or the site. An IHE that hosts or is affiliated with a site must, in order to remain eligible for federal funds, annually certify that the site does not provide abortion drugs or abortions to students or employees.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4362

Introduced
6/23/23  
Refer
6/23/23  
Refer
6/23/23  
Saving Organs One Flight at a Time Act
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB438

Introduced
1/20/23  
True Cost Act This bill requires the President's annual budget submission to Congress to include estimates of the cost per individual taxpayer for (1) the public debt, and (2) any projected budget deficit for a fiscal year.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4468

Introduced
7/6/23  
Refer
7/6/23  
Refer
7/7/23  
Report Pass
7/27/23  
Choice in Automobile Retail Sales Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4490

Introduced
7/6/23  
Refer
7/6/23  
To amend the Controlled Substances Act to authorize pharmacies to deliver certain controlled substances to an administering practitioner in lieu of delivering such substances to the ultimate user, and for other purposes.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4529

Introduced
7/11/23  
Refer
7/11/23  
Refer
7/11/23  
Public Health Guidance Transparency and Accountability Act of 2023
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4531

Introduced
7/11/23  
Refer
7/11/23  
Report Pass
7/19/23  
Report Pass
9/28/23  
Support for Patients and Communities Reauthorization Act

Primary Sponsor of Legislation

US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4242

Introduced
6/21/23  
Refer
6/21/23  
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.
US

Us Congress 2023-2024 Regular Session

Us Congress House Bill HB4516

Introduced
7/10/23  
Refer
7/10/23  
To amend the Public Health Service Act to provide for the inclusion of a biological attribution strategy, and an early warning strategy and implementation plan, in the National Health Security Strategy, and for other purposes.